Important pharmacy news and late-breaking industry information updated daily.
The Ohio Pharmacists Association (OPA) announced at its annual conference on Friday the creation of a task force to promote safe medication practices that prevent powerful opioids from getting into the wrong hands.
JAPhA study: Pharmacists may help improve appropriate use and disposal
An FDA advisory panel on Thursday unanimously recommended approval of a prescription cannabidiol medication for the treatment of rare forms of epilepsy.
A group of cancer doctors focused on bringing down the cost of treatments by testing whether lower doses are effective thought they had found a prime candidate in the blood cancer drug ibrutinib (Imbruvica—Pharmacyclics) that typically costs $148,000 a year.
Attorney General Jeff Sessions on Tuesday proposed new regulations that could severely limit the amount of opioids that drug companies can produce and force them to account for scores of illegitimate prescriptions across the country. The regulations would change how DEA sets production quotas for drug manufacturers.
Safety violations at a major compounding pharmacy are exacerbating hospital shortages of opioid analgesics, particularly in California where health officials have prohibited sales from one of its plants. In late March, California's Board of Pharmacy barred the distribution of medications from a Texas factory belonging to the company, PharMEDium.
Pharmacist-led comprehensive medication management may be the solution
FDA on Friday issued a new <a href="https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatory…; target="_blank">guidance</a> to clarify that dietary supplements containing pure or highly concentrated caffeine in powder or liquid forms are considered unlawful when sold in bulk quantities directly to consumers.
Policy makers speak highly of pharmacy’s important role in addressing opioid epidemic
Findings might offer relief to those with comorbid headaches and depression